ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline PDYN Q1 2026 Earnings WiderThanExpected Loss Raises Questions Stock Edges Higher AGNCN Q1 2026 Earnings EPS Surpasses Estimates by 145 Artesian Resources Corporation ARTNA Q3 2025 Earnings Marginal EPS Beat Amid Steady Utility Operations CTNM Q1 2026 Earnings Narrowed Loss Exceeds Expectations as Pipeline Advances BABA Q1 2026 Earnings Massive EPS Miss Shakes Investor Confidence